News
OPEN Health appoints Seth Nickerson as Global Client Partner
Written on Wednesday, May 27, 2026
May 27, 2026 – New York and London – OPEN Health today announced the appointment of Seth Nickerson, PhD as Global Client Partner, strengthening the organisation’s ability to help biopharma companies align evidence, strategy, and engagement across the product lifecycle.
In this role, Seth will partner with global biopharma organisations to bring together evidence generation, medical strategy, market access, scientific communications, and stakeholder engagement into more connected and coordinated approaches that support better healthcare decisions.
“After many years on the sponsor side leading medical affairs strategy, I kept seeing the same challenge: the disciplines that shape a product’s success are too often managed in isolation,” said Seth Nickerson. “What drew me to OPEN Health is its ability to connect those capabilities into one strategic arc, from evidence planning and scientific narrative development through to access, education, and engagement. When that integration is real, the impact compounds across the entire lifecycle.”
Seth joins OPEN Health with extensive experience leading integrated medical affairs and strategic initiatives across the biopharma industry. Having worked closely within sponsor organisations, he brings deep understanding of the commercial, scientific, and cross-functional dynamics that shape enterprise-level priorities and decision-making.
He will work closely with teams and clients across OPEN Health to strengthen strategic partnerships, support integrated evidence and communications planning, and help clients connect upstream strategy with downstream execution across the healthcare ecosystem.
“The decisions that shape access, uptake, and patient impact are made long before launch,” Seth added. “They are shaped through evidence strategy, scientific storytelling, and how stakeholder conversations are sequenced across the lifecycle. I’m excited to help clients move from fragmented activities to coordinated strategies that reshape treatment landscapes and support better decisions in the moments that matter most.”
“Seth brings a powerful combination of sponsor-side experience, strategic perspective, and deep understanding of the challenges our clients face every day,” said Zack Lentz, Chief Commercial Officer at OPEN Health. “His ability to connect evidence, strategy, and communications into integrated solutions reflects where the industry is heading and reinforces OPEN Health’s role as a science-to-decision partner helping clients navigate complexity with greater clarity, alignment, and impact.”
Seth’s appointment reflects OPEN Health’s continued investment in strategic client leadership and integrated partnership capabilities as the organisation continues to expand its support for global healthcare and biopharma clients.